@dbdsstanford.bsky.social
Kristy Carpenter wins the “Drug Repurposing” NIDA Challenge and may have solved an even bigger issue with her research
Read the story here: dbds.stanford.edu/kristy-carpe...
Read the story here: dbds.stanford.edu/kristy-carpe...
June 11, 2025 at 5:36 PM
Kristy Carpenter wins the “Drug Repurposing” NIDA Challenge and may have solved an even bigger issue with her research
Read the story here: dbds.stanford.edu/kristy-carpe...
Read the story here: dbds.stanford.edu/kristy-carpe...
DBDS chair Sylvia Plevritis, Professor Nigam Shah, and Ph.D. student Timothy Keyes are featured in a video presented by CEO Satya Nadella during the Microsoft Build 2025 opening keynote on May 19.
Watch it here: www.youtube.com/watch?v=DSOc....
Watch it here: www.youtube.com/watch?v=DSOc....
Stanford Medicine and the healthcare agent orchestrator: Satya Nadella at Microsoft Build 2025
YouTube video by Microsoft
www.youtube.com
June 5, 2025 at 5:49 PM
DBDS chair Sylvia Plevritis, Professor Nigam Shah, and Ph.D. student Timothy Keyes are featured in a video presented by CEO Satya Nadella during the Microsoft Build 2025 opening keynote on May 19.
Watch it here: www.youtube.com/watch?v=DSOc....
Watch it here: www.youtube.com/watch?v=DSOc....
Harrison Zhang, an MD-PhD student and incoming student in the DBDS PhD program this fall was recently awarded the Knight-Hennessy Scholarship.
Congratulations, Harrison!
Read the story here: knight-hennessy.stanford.edu/news/knight-...
Congratulations, Harrison!
Read the story here: knight-hennessy.stanford.edu/news/knight-...
May 27, 2025 at 5:35 PM
Harrison Zhang, an MD-PhD student and incoming student in the DBDS PhD program this fall was recently awarded the Knight-Hennessy Scholarship.
Congratulations, Harrison!
Read the story here: knight-hennessy.stanford.edu/news/knight-...
Congratulations, Harrison!
Read the story here: knight-hennessy.stanford.edu/news/knight-...
Timothy Keyes from the Shah lab featured in Microsoft Source story, "Meet 4 Developers Leading the Way With AI Agents"
Read the story here: news.microsoft.com/source/featu...
Read the story here: news.microsoft.com/source/featu...
4 developers leading the way with AI agents
AI agents are helping developers code faster to help solve business problems.
news.microsoft.com
May 22, 2025 at 6:40 PM
Timothy Keyes from the Shah lab featured in Microsoft Source story, "Meet 4 Developers Leading the Way With AI Agents"
Read the story here: news.microsoft.com/source/featu...
Read the story here: news.microsoft.com/source/featu...
stat4onc.org/events/stat4...
Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, & regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care. REGISTER NOW!
Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, & regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care. REGISTER NOW!
Stat4Onc Annual Symposium (2025) : Home
stat4onc.org
May 14, 2025 at 10:13 PM
stat4onc.org/events/stat4...
Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, & regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care. REGISTER NOW!
Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, & regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care. REGISTER NOW!
Roxana Daneshjou joins host Peter Lee on "The AI Revolution in Medicine, Revisited" podcast to discuss the responsible implementation of AI in healthcare, identifying mitigating bias in AI systems and also leveraging AI to better serve patient needs.
Listen here: www.microsoft.com/en-us/resear...
Listen here: www.microsoft.com/en-us/resear...
Laws, norms, and ethics for AI in health
In Episode 4 of “The AI Revolution in Medicine, Revisited,” guests Laura Adams, Vardit Ravitsky, and Dr. Roxana Daneshjou explore how to responsibly implement AI in medicine, from governance and fairn...
www.microsoft.com
May 14, 2025 at 4:00 PM
Roxana Daneshjou joins host Peter Lee on "The AI Revolution in Medicine, Revisited" podcast to discuss the responsible implementation of AI in healthcare, identifying mitigating bias in AI systems and also leveraging AI to better serve patient needs.
Listen here: www.microsoft.com/en-us/resear...
Listen here: www.microsoft.com/en-us/resear...
AI Frontiers of Healthcare and Medicine Summit delivers exciting opportunity for collaboration between industry, biopharma, and DBDS
Read the story here: dbds.stanford.edu/ai-frontiers...
Read the story here: dbds.stanford.edu/ai-frontiers...
May 12, 2025 at 9:12 PM
AI Frontiers of Healthcare and Medicine Summit delivers exciting opportunity for collaboration between industry, biopharma, and DBDS
Read the story here: dbds.stanford.edu/ai-frontiers...
Read the story here: dbds.stanford.edu/ai-frontiers...
James Zou in StatNews: AI agents in health care: Everything you need to know, but didn’t know how to ask
AI agents differ from earlier generations of AI tools, but hurdles stand in the way of wider adoption
Read more: www.statnews.com/2025/04/09/a...
AI agents differ from earlier generations of AI tools, but hurdles stand in the way of wider adoption
Read more: www.statnews.com/2025/04/09/a...
AI agents in health care: Everything you need to know, but didn't know how to ask
AI agents are finding their way into the world of health care, but tech developers may be more excited than clinicians.
www.statnews.com
April 21, 2025 at 7:44 PM
James Zou in StatNews: AI agents in health care: Everything you need to know, but didn’t know how to ask
AI agents differ from earlier generations of AI tools, but hurdles stand in the way of wider adoption
Read more: www.statnews.com/2025/04/09/a...
AI agents differ from earlier generations of AI tools, but hurdles stand in the way of wider adoption
Read more: www.statnews.com/2025/04/09/a...
Curt Langlotz in Washington Post: AI hasn't killed radiology, but it is changing it
"AI is not a better kind of intelligence, it's a different kind of intelligence," Langlotz says. "A human plus a machine is better than either one alone."
Read more here: wapo.st/4jk7cmB
"AI is not a better kind of intelligence, it's a different kind of intelligence," Langlotz says. "A human plus a machine is better than either one alone."
Read more here: wapo.st/4jk7cmB
AI hasn’t killed radiology, but it is changing it
About two-thirds of radiology departments in the United States use AI in some capacity, according to a recent unpublished survey.
wapo.st
April 17, 2025 at 3:05 PM
Curt Langlotz in Washington Post: AI hasn't killed radiology, but it is changing it
"AI is not a better kind of intelligence, it's a different kind of intelligence," Langlotz says. "A human plus a machine is better than either one alone."
Read more here: wapo.st/4jk7cmB
"AI is not a better kind of intelligence, it's a different kind of intelligence," Langlotz says. "A human plus a machine is better than either one alone."
Read more here: wapo.st/4jk7cmB
Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, and regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care.
REGISTER NOW!
stat4onc.org/events/stat4...
REGISTER NOW!
stat4onc.org/events/stat4...
Stat4Onc Annual Symposium (2025) : Home
stat4onc.org
April 16, 2025 at 9:06 PM
Stat4Onc Annual Symposium, NCI sponsored, fosters discussions between scientists on cancer clinical trials. Academia, industry, and regulatory agencies share research, collaborate on solutions for trial design, drug development & patient care.
REGISTER NOW!
stat4onc.org/events/stat4...
REGISTER NOW!
stat4onc.org/events/stat4...
Alumna Daisy Ding, et al., introduce MESA, a spatial omics framework that integrates multiomics data to study the spatial architecture of tissues in health and disease, was pubbed by Nature Genetics. This study, in part, was based on Ding’s DBDS Ph.D thesis.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Quantitative characterization of tissue states using multiomics and ecological spatial analysis - Nature Genetics
Multiomics and ecological spatial analysis (MESA) calculates ecodiversity-inspired metrics in spatially resolved omics integrated with single-cell data, enabling the quantitative comparison of tissue ...
www.nature.com
April 11, 2025 at 3:45 PM
Alumna Daisy Ding, et al., introduce MESA, a spatial omics framework that integrates multiomics data to study the spatial architecture of tissues in health and disease, was pubbed by Nature Genetics. This study, in part, was based on Ding’s DBDS Ph.D thesis.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Nima Agheepour in Nature Medicine: AI can help doctors give intravenous nutrition to preemies
An algorithm that learned from tens of thousands of nutrition prescriptions for premature babies could reduce medical errors....
Read it here: med.stanford.edu/news/all-new...
An algorithm that learned from tens of thousands of nutrition prescriptions for premature babies could reduce medical errors....
Read it here: med.stanford.edu/news/all-new...
AI can help doctors give intravenous nutrition to preemies, Stanford Medicine study finds
An algorithm that learned from tens of thousands of nutrition prescriptions for premature babies could reduce medical errors and better identify what nutrients the smallest patients need.
med.stanford.edu
April 8, 2025 at 5:41 PM
Nima Agheepour in Nature Medicine: AI can help doctors give intravenous nutrition to preemies
An algorithm that learned from tens of thousands of nutrition prescriptions for premature babies could reduce medical errors....
Read it here: med.stanford.edu/news/all-new...
An algorithm that learned from tens of thousands of nutrition prescriptions for premature babies could reduce medical errors....
Read it here: med.stanford.edu/news/all-new...
"Auditing the inference processes of medical-image classifiers by leveraging generative AI and the expertise of physicians" by Roxana Daneshjou (et all) was featured on the latest cover of Nature Biomedical Engineering.
www.nature.com/natbiomedeng...
www.nature.com/natbiomedeng...
March 27, 2025 at 5:29 PM
"Auditing the inference processes of medical-image classifiers by leveraging generative AI and the expertise of physicians" by Roxana Daneshjou (et all) was featured on the latest cover of Nature Biomedical Engineering.
www.nature.com/natbiomedeng...
www.nature.com/natbiomedeng...
Zou Lab launches MedArena, a free platform for clinicians to use and compare frontier LLMs
MedArena is a free platform for clinicians to use and compare how frontier LLMs work on medical queries.
Check it out at: medarena.ai/login
MedArena is a free platform for clinicians to use and compare how frontier LLMs work on medical queries.
Check it out at: medarena.ai/login
March 26, 2025 at 6:54 PM
Zou Lab launches MedArena, a free platform for clinicians to use and compare frontier LLMs
MedArena is a free platform for clinicians to use and compare how frontier LLMs work on medical queries.
Check it out at: medarena.ai/login
MedArena is a free platform for clinicians to use and compare how frontier LLMs work on medical queries.
Check it out at: medarena.ai/login
Experimental Design: AI for Science, April 3-4
March 10, 2025 at 6:25 PM
Experimental Design: AI for Science, April 3-4
DBDS' James Zou awarded Overton Prize.
Awarded by ISCB, the prize recognizes the research, education, and service accomplishments of early to mid-career scientists who are emerging leaders in computational biology.
dbds.stanford.edu/james-zou-wi...
Awarded by ISCB, the prize recognizes the research, education, and service accomplishments of early to mid-career scientists who are emerging leaders in computational biology.
dbds.stanford.edu/james-zou-wi...
March 5, 2025 at 10:01 PM
DBDS' James Zou awarded Overton Prize.
Awarded by ISCB, the prize recognizes the research, education, and service accomplishments of early to mid-career scientists who are emerging leaders in computational biology.
dbds.stanford.edu/james-zou-wi...
Awarded by ISCB, the prize recognizes the research, education, and service accomplishments of early to mid-career scientists who are emerging leaders in computational biology.
dbds.stanford.edu/james-zou-wi...
“Experimental Design: AI for Science” at Stanford 4/3-4/4. The workshop focuses on theory/methodology of AI-based experimental design & has an exciting lineup of speakers including David Baker, Nobel Prize winner. Faculty, students & postdocs invited.
More information: edai4science.github.io
More information: edai4science.github.io
March 3, 2025 at 11:06 PM
“Experimental Design: AI for Science” at Stanford 4/3-4/4. The workshop focuses on theory/methodology of AI-based experimental design & has an exciting lineup of speakers including David Baker, Nobel Prize winner. Faculty, students & postdocs invited.
More information: edai4science.github.io
More information: edai4science.github.io
Dr. Mikel Hernaez at CIMA & Gevaert lab benchmarked inductive and transductive methods for drug target interaction discovery: Transductive methods don't lead to inflated performance when traditionally evaluated, making them unsuitable for drug repurposing.
www.nature.com/articles/s42...
www.nature.com/articles/s42...
Towards a more inductive world for drug repurposing approaches - Nature Machine Intelligence
The authors address the challenge of predicting drug–target interactions, which is crucial for drug repurposing, by introducing a robust benchmarking framework. Using a biologically driven strategy, t...
www.nature.com
February 24, 2025 at 10:55 PM
Dr. Mikel Hernaez at CIMA & Gevaert lab benchmarked inductive and transductive methods for drug target interaction discovery: Transductive methods don't lead to inflated performance when traditionally evaluated, making them unsuitable for drug repurposing.
www.nature.com/articles/s42...
www.nature.com/articles/s42...
Grand Rounds, Nigam Shah, 2/25
Time: 9:00-10:00am PT
Format: Live webinar presentation and Q&A
Registration: Open to the Stanford and AIMI affiliate community
Register Here: stanford.zoom.us/webinar/regi...
Time: 9:00-10:00am PT
Format: Live webinar presentation and Q&A
Registration: Open to the Stanford and AIMI affiliate community
Register Here: stanford.zoom.us/webinar/regi...
February 21, 2025 at 5:35 PM
Grand Rounds, Nigam Shah, 2/25
Time: 9:00-10:00am PT
Format: Live webinar presentation and Q&A
Registration: Open to the Stanford and AIMI affiliate community
Register Here: stanford.zoom.us/webinar/regi...
Time: 9:00-10:00am PT
Format: Live webinar presentation and Q&A
Registration: Open to the Stanford and AIMI affiliate community
Register Here: stanford.zoom.us/webinar/regi...
Reposted
Incredibly grateful and honored to receive the 2025 Overton Prize ♥️
Surreal to follow the steps of my science heroes🙏 Truly, credit goes to my amazing students, collaborators and mentors who make research so inspiring!
Also underscores the value of open academic environment that make this possible
Surreal to follow the steps of my science heroes🙏 Truly, credit goes to my amazing students, collaborators and mentors who make research so inspiring!
Also underscores the value of open academic environment that make this possible
February 20, 2025 at 4:39 PM
Incredibly grateful and honored to receive the 2025 Overton Prize ♥️
Surreal to follow the steps of my science heroes🙏 Truly, credit goes to my amazing students, collaborators and mentors who make research so inspiring!
Also underscores the value of open academic environment that make this possible
Surreal to follow the steps of my science heroes🙏 Truly, credit goes to my amazing students, collaborators and mentors who make research so inspiring!
Also underscores the value of open academic environment that make this possible
Christina Curtis in the Stanford Report: Studying DNA variations in breast cancer tumors could improve treatment and recurrence screening
Read it here: news.stanford.edu/stories/2025...
Read it here: news.stanford.edu/stories/2025...
Studying DNA variations in breast cancer tumors could improve treatment and recurrence screening
Exploring the genomic architecture of breast cancer development could reveal new therapeutic options, Stanford Medicine research reveals.
news.stanford.edu
February 20, 2025 at 7:23 PM
Christina Curtis in the Stanford Report: Studying DNA variations in breast cancer tumors could improve treatment and recurrence screening
Read it here: news.stanford.edu/stories/2025...
Read it here: news.stanford.edu/stories/2025...
Manny Rivas and Larissa Lauer in BioRx: Unified meta regression models for rare variant association studies
Rare variant association studies (RVAS) of complex traits have emerged as a powerful approach to advance drug discovery and diagnostics.
Read more here: www.biorxiv.org/content/10.1...
Rare variant association studies (RVAS) of complex traits have emerged as a powerful approach to advance drug discovery and diagnostics.
Read more here: www.biorxiv.org/content/10.1...
Unified meta regression models for rare variant association studies
Rare variant association studies (RVAS) of complex traits have emerged as a powerful approach to advance drug discovery and diagnostics. Missense pathogenicity predictions from AlphaMissense based on ...
www.biorxiv.org
February 19, 2025 at 6:57 PM
Manny Rivas and Larissa Lauer in BioRx: Unified meta regression models for rare variant association studies
Rare variant association studies (RVAS) of complex traits have emerged as a powerful approach to advance drug discovery and diagnostics.
Read more here: www.biorxiv.org/content/10.1...
Rare variant association studies (RVAS) of complex traits have emerged as a powerful approach to advance drug discovery and diagnostics.
Read more here: www.biorxiv.org/content/10.1...
James Zou: "The rise of agentic AI teammates in medicine," The Lancet
"Medicine is in the dawn of a fundamental shift from using artificial intelligence (AI) as tools to deploying AI as agents..."
Read more here: www.thelancet.com/journals/lan...
"Medicine is in the dawn of a fundamental shift from using artificial intelligence (AI) as tools to deploying AI as agents..."
Read more here: www.thelancet.com/journals/lan...
The rise of agentic AI teammates in medicine
Medicine is in the dawn of a fundamental shift from using artificial intelligence
(AI) as tools to deploying AI as agents. When used as a tool, AI is passive and reactive.
Even powerful medical AI fou...
www.thelancet.com
February 14, 2025 at 7:53 PM
James Zou: "The rise of agentic AI teammates in medicine," The Lancet
"Medicine is in the dawn of a fundamental shift from using artificial intelligence (AI) as tools to deploying AI as agents..."
Read more here: www.thelancet.com/journals/lan...
"Medicine is in the dawn of a fundamental shift from using artificial intelligence (AI) as tools to deploying AI as agents..."
Read more here: www.thelancet.com/journals/lan...
“This is a new era for us,” Chair of the Department of Biomedical Data Science Sylvia Plevritis began, opening the third annual Collaboration & Careers Forum on January 16, 2025.
Read the story here: dbds.stanford.edu/collaboratio...
Read the story here: dbds.stanford.edu/collaboratio...
February 12, 2025 at 7:06 PM
“This is a new era for us,” Chair of the Department of Biomedical Data Science Sylvia Plevritis began, opening the third annual Collaboration & Careers Forum on January 16, 2025.
Read the story here: dbds.stanford.edu/collaboratio...
Read the story here: dbds.stanford.edu/collaboratio...
Purvesh Khatri and BMI postdoc Tim Sweeney have been working on developing blood-based signatures for presence, type, and severity of infection for 7 years. The signatures were licensed by Inflammatix, Inc. This week, a test based on those signatures, TriVerity, received and FDA clearance. Congrats!
February 10, 2025 at 6:29 PM
Purvesh Khatri and BMI postdoc Tim Sweeney have been working on developing blood-based signatures for presence, type, and severity of infection for 7 years. The signatures were licensed by Inflammatix, Inc. This week, a test based on those signatures, TriVerity, received and FDA clearance. Congrats!